Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and ...
Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma Recommendation based on IMROZ phase 3 study demonstrating Sarclisa in ...
A booster to transform breakthrough technologies and processes developed by best-in-class academic partners and start-ups into innovative solutions to accelerate our R&D portfolio. In 2022, the ...
Although presymptomatic T1D (Stages 1 and 2) can be detected months or years before symptoms appear, most people are not diagnosed until they feel unwel. 10 11 Over the past 50 years, scientists ...
Janvier 2022 a marqué un tournant dans la prise en charge du diabète de Type 1. Après plus d’un siècle de traitements à base d’insuline, patients et médecins ont désormais une nouvelle option : la ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback